Nitrous Oxide Analgesia Vaso-occlusive Crisis
Nitrous Oxide for Analgesia in Sickle Cell Vaso-occlusive Crisis
Sponsor: Columbia University
This PHASE2 trial investigates Sickle Cell Disease and Vaso-occlusive Crisis and is currently completed. Columbia University leads this study, which shows 12 recorded versions since 2013 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
12 versions recorded-
Feb 2026 — Present [monthly]
Completed PHASE2
-
Feb 2026 — Present [monthly]
Completed PHASE2
Status: Terminated → Completed
-
Jan 2026 — Present [monthly]
Terminated PHASE2
-
Sep 2024 — Feb 2026 [monthly]
Terminated PHASE2
-
Aug 2024 — Sep 2024 [monthly]
Terminated PHASE2
▶ Show 7 earlier versions
-
Jul 2024 — Aug 2024 [monthly]
Terminated PHASE2
-
Sep 2021 — Jul 2024 [monthly]
Terminated PHASE2
Status: Completed → Terminated
-
Jan 2021 — Sep 2021 [monthly]
Completed PHASE2
-
Nov 2020 — Jan 2021 [monthly]
Completed PHASE2
Status: Recruiting → Completed
-
Feb 2019 — Nov 2020 [monthly]
Recruiting PHASE2
-
Jun 2018 — Feb 2019 [monthly]
Recruiting PHASE2
-
Jan 2017 — Jun 2018 [monthly]
Recruiting PHASE2
First recorded
Nov 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Columbia University
For direct contact, visit the study record on ClinicalTrials.gov .